أرسل هذا في رسالة قصيرة: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

 __   __    _____    _    _      ___     __   _   
 \ \\/ //  |  ___|| | || | ||   / _ \\  | || | || 
  \   //   | ||__   | || | ||  | / \ || | '--' || 
  / . \\   | ||__   | \\_/ ||  | \_/ || | .--. || 
 /_//\_\\  |_____||  \____//    \___//  |_|| |_|| 
 `-`  --`  `-----`    `---`     `---`   `-`  `-`